Volpara Health Technologies (ASX: VHT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Volpara Health Technologies Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Volpara Health Technologies (ASX: VHT)
    Latest News

    happy woman throws arms in the air
    Small Cap Shares

    2 buy-rated small cap ASX shares

    These small caps have buy ratings on their shares...

    Read more »

    a happy investor with a wide smile points to a graph that shows an upward trending share price
    Small Cap Shares

    3 growing small cap ASX shares named as buys

    These small caps have been tipped as buys...

    Read more »

    Plants in three yellow pots, inidctaing three levels of growth
    Technology Shares

    2 ASX shares that may be worth looking at this weekend

    BetaShares Asia Technology Tigers ETF and Volpara could be two ASX shares to think about.

    Read more »

    A man looking at ASX share price movements on his computer screen.
    Small Cap Shares

    3 small cap ASX shares to put on your watchlist this week

    These small caps could be worth watching closely...

    Read more »

    ASX shares upgrade buy Woman in glasses writing on buy on board
    Growth Shares

    2 ASX shares that could be buys in August 2021

    Volpara and Adairs are two ASX shares that could be worth watching.

    Read more »

    Green keyboard button saying buy stock
    Small Cap Shares

    2 small cap ASX shares that this broker rates as buys

    These small cap shares could be going places...

    Read more »

    Graphic showing yellow arrow above vertical columns indicating a rising share price
    Growth Shares

    2 great ASX shares to think about

    Australian Ethical could be one of the leading ASX shares to consider.

    Read more »

    stock market gaining
    Growth Shares

    2 top ASX growth shares reporting strong growth

    Both Temple & Webster and Volpara are growing strongly.

    Read more »

    Woman preparing to have her breast screened with the support of a young female doctor.
    Share Market News

    Here's why the Volpara (ASX:VHT) share price is on the move today

    Volpara Health and Invitae are set to collaborate.

    Read more »

    Monadelphous share price rio tinto A small rocket take off from a laptop, indicating a share price surge
    Share Market News

    2 great ASX tech shares that could be buys

    Volpara and Class are two ASX tech shares that could be opportunities.

    Read more »

    comical investor reading documents and surrounded by calculators
    Growth Shares

    2 ASX shares that could be worth looking at this weekend

    There are at least two ASX shares that could be worth thinking about this weekend.

    Read more »

    Small Cap Shares

    3 growing small cap ASX shares to watch

    Keep an eye on these small cap shares...

    Read more »

    Frequently Asked Questions

    No, the ASX healthcare share has not yet paid any dividends.

    Volpara listed on 27 April 2016.

    VHT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Volpara Health Technologies

    Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.

    Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.

    Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Teri Thomas Chief Executive OfficerManaging Director Apr 2022
    Teri joined the Board in October 2022. She has a
    long history of executive management in healthcare
    IT ranging from strategy and operations to running
    global sales and marketing teams. This includes a
    20-year career at Epic, a global leader in electronic
    health record (EHR) systems and other software
    solutions used by hospitals and healthcare
    organisations in the United States and internationally
    Mr Craig Hadfield Chief Financial OfficerJoint Company Secretary Mar 2017
    -
    Mr Fred Struve General CounselJoint Company Secretary Oct 2022
    -
    Craig Hadfield Chief Financial OfficerJoint Company Secretary
    -
    Fred Struve General CounselJoint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 27,534,688 10.84%
    Patagorang Pty Ltd 18,467,848 7.27%
    Ralph Highnam And Kyc Trustees 106 Limited <Highnam Share A/C> 16,213,561 6.38%
    Citicorp Nominees Pty Limited 11,830,450 4.66%
    HSBC Custody Nominees (Australia) Limited 8,187,911 3.22%
    Custodial Services Limited <Beneficiaries Holding A/C> 8,154,911 3.21%
    Bnp Paribas Noms (Nz) Ltd <Drp> 7,061,556 2.78%
    Prof Sir Michael Brady 6,619,075 2.61%
    Mr Marcus Sarner 5,980,404 2.35%
    National Nominees Limited 4,728,818 1.86%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient 4,420,193 1.74%
    Sir Martin Francis Wood 3,004,655 1.18%
    Lady Kathleen Audrey Wood 3,004,654 1.18%
    BNP Paribas Noms Pty Ltd <Drp> 2,527,511 0.99%
    Prof Martin Yaffe 1,966,483 0.77%
    Mr John Anthony Dell 1,928,864 0.76%
    BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Limited 1,917,409 0.75%
    Prof Nico Karssemeijer 1,806,806 0.71%
    Melbourne Securities Corporation Limited <Horizon 3 Biotech Fund A/C> 1,519,964 0.60%
    RX HOUSE TRUST PTY LTD 880,758 0.35%

    Profile

    since

    Note